Roles of exosomes and microvesicles in disease pathogenesis

Advanced Drug Delivery Reviews

Volumn 65, Issue 3, 2013, Pages 398-401

  Ohno, Shin ichiro ^a   Ishikawa, Akio ^a   Kuroda, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Exosome; Immunology; Infectious disease; Microvesicle; Morphology; Neurological disease

Indexed keywords

ANTIGEN PRESENTATION; CELL-CELL COMMUNICATIONS; CLINICAL DIAGNOSIS; EXOSOME; INFECTIOUS DISEASE; MICROVESICLE; NEUROLOGICAL DISEASE; PROGNOSTIC MARKERS;

CELLS; CYTOLOGY; IMMUNOLOGY; MORPHOLOGY;

DIAGNOSIS;

AQUAPORIN 2; BIOLOGICAL MARKER; CAVEOLIN 1; CD63 ANTIGEN; EPITHELIAL CELL ADHESION MOLECULE; FETUIN A; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MELANOMA ANTIGEN 1; MICRORNA; NATURAL KILLER CELL RECEPTOR NKG2D; THROMBOPLASTIN; THROMBOSPONDIN 2; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN PRESENTATION; CANCER CELL; CANCER SURVIVAL; CELL COMMUNICATION; CELL FUSION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EXOSOME; HUMAN; HUMAN CELL; MEMBRANE VESICLE; MICROVESICLE; NATURAL KILLER CELL; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW;

ANTIGEN PRESENTATION; BIOLOGICAL MARKERS; CELL COMMUNICATION; CELL MEMBRANE; COMMUNICABLE DISEASES; EXOSOMES; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 84874995435     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.07.019     Document Type: Review

References (54)

1. Théry C., Amigorena S., Raposo G., Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Current Protocols in Cell Biology 2001, John Wiley & Sons, Inc.
2. Théry C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
3. Février B., Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 2004, 16:415-421.
4. van Niel G. Exosomes: a common pathway for a specialized function. J. Biochem. 2006, 140:13-21.
5. Trajkovic K., Hsu C., Chiantia S., Rajendran L., Wenzel D., Wieland F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 2008, 319:1244-1247.
6. Camussi G., Deregibus M.C., Bruno S., Grange C., Fonsato V., Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am. J. Cancer Res. 2011, 1:98-110.
7. Friend C., Marovitz W., Henie G., Henie W., Tsuei D., Hirschhorn K., et al. Observations on cell lines derived from a patient with Hodgkin's disease. Cancer Res. 1978, 38:2581-2591.
8. Mitchell P.J., Welton J., Staffurth J., Court J., Mason M.D., Tabi Z., et al. Can urinary exosomes act as treatment response markers in prostate cancer?. J. Transl. Med. 2009, 7:4.
9. Kim H.K., Song K.S., Park Y.S., Kang Y.H., Lee Y.J., Lee K.R., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Cancer 2003, 39:184-191.
10. Helley D., Banu E., Bouziane A., Banu A., Scotte F., Fischer A.-M., et al. Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur. Urol. 2009, 56:479-485.
11. Tesselaar M.E., Romijn F.P., Van Der Linden I.K., Prins F.A., Bertina R.M., Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J. Thromb. Haemost. 2007, 5:520-527.
12. Smalley D.M., Sheman N.E., Nelson K., Theodorescu D. Isolation and identification of potential urinary microparticle biomarkers of bladder cancer. J. Proteome Res. 2008, 7:2088-2096.
13. Baran J., Baj-Krzyworzeka M., Weglarczyk K., Szatanek R., Zembala M., Barbasz J., et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol. Immunother. 2009, 59:841-850.
14. Skog J., Würdinger T., van Rijn S., Meijer D.H., Gainche L., Curry W.T., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
15. Nilsson J., Skog J., Nordstrand A., Baranov V., Mincheva-Nilsson L., Breakefield X.O., et al. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br. J. Cancer 2009, 100:1603-1607.
16. Redman C.W., Tannetta D.S., Dragovic R.A., Gardiner C., Southcombe J.H., Collett G.P., et al. Review: does size matter? Placental debris and the pathophysiology of pre-eclampsia. Placenta 2012, 33:S48-54. (Suppl.).
17. Tanaka M., Oikawa K., Takanashi M., Kudo M., Ohyashiki J., Ohyashiki K., et al. Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One 2009, 4:e5532.
18. Ohyashiki J.H., Umezu T., Kobayashi C., Hamamura R.S., Tanaka M., Kuroda M., et al. Impact on cell to plasma ratio of miR-92a in patients with acute leukemia: in vivo assessment of cell to plasma ratio of miR-92a. BMC Res. Notes 2010, 3:347.
19. Shigoka M., Tsuchida A., Matsudo T., Nagakawa Y., Saito H., Suzuki Y., et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development. Pathol. Int. 2010, 60:351-357.
20. Ng E.K.O., Chong W.W.S., Jin H., Lam E.K.Y., Shin V.Y., Yu J., et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009, 58:1375-1381.
21. Huang Z., Huang D., Ni S., Peng Z., Sheng W., Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int. J. Cancer 2010, 127:118-126.
22. Navarro A., Cheng H., Zhang L., Cogdell D.E., Zheng H., Schetter A.J., et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One 2011, 6:e17745.
23. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. 2011, 108:5003-5008.
24. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010, 38:7248-7259.
25. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat. Cell Biol. 2011, 13:423-433.
26. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med. 1996, 183:1161-1172.
27. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 1998, 4:594-600.
28. Clayton A., Mitchell J.P., Court J., Mason M.D., Tabi Z. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 2007, 67:7458-7466.
29. Clayton A., Mitchell J.P., Court J., Linnane S., Mason M.D., Tabi Z. Human tumor-derived exosomes down-modulate NKG2D expression. J. Immunol. 2008, 180:7249-7258.
30. Wolfers J., Lozier A., Raposo G., Regnault A., Thery C., Masurier C., et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 2001, 7:297-303.
31. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 2008, 10:619-624.
32. Park J.E., Tan H.S., Datta A., Lai R.C., Zhang H., Meng W., et al. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 2010, 9:1085-1099.
33. Gould S.J. The Trojan exosome hypothesis. Proc. Natl. Acad. Sci. 2003, 100:10592-10597.
34. Izquierdo-Useros N., Naranjo-Gomez M., Erkizia I., Puertas M.C., Borras F.E., Blanco J., et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse?. PLoS Pathog. 2010, 6:e1000740.
35. Mori Y., Koike M., Moriishi E., Kawabata A., Tang H., Oyaizu H., et al. Human herpesvirus-6 induces MVB formation, and virus egress occurs by an exosomal release pathway. Traffic 2008, 9:1728-1742.
36. Tamai K., Shiina M., Tanaka N., Nakano T., Yamamoto A., Kondo Y., et al. Regulation of hepatitis C virus secretion by the Hrs-dependent exosomal pathway. Virology 2012, 422:377-385.
37. Wiley R.D. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc. Natl. Acad. Sci. 2006, 103:738-743.
38. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A.J., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc. Natl. Acad. Sci. 2010, 107:6328-6333.
39. Prusiner S.B., Scott M.R., DeArmond S.J., Cohen F.E. Prion protein biology. Cell 1998, 93:337-348.
40. Harris D.A. Cellular biology of prion diseases. Clin. Microbiol. Rev. 1999, 12:429-444.
41. Fevrier B. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. 2004, 101:9683-9688.
42. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
43. Rajendran L. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc. Natl. Acad. Sci. 2006, 103:11172-11177.
44. de Gassart A. Lipid raft-associated protein sorting in exosomes. Blood 2003, 102:4336-4344.
45. Katzmann D.J., Babst M., Emr S.D. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001, 106:145-155.
46. Kanno K., Sasaki S., Hirata Y., Ishikawa S., Fushimi K., Nakanishi S., et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N. Engl. J. Med. 1995, 332:1540-1545.
47. Bard M.P., Hegmans J.P., Hemmes A., Luider T.M., Willemsen R., Severijnen L.A., et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 2004, 31:114-121.
48. Zhou H., Pisitkun T., Aponte A., Yuen P.S., Hoffert J.D., Yasuda H., et al. Exosomal fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int. 2006, 70:1847-1857.
49. Runz S., Keller S., Rupp C., Stoeck A., Issa Y., Koensgen D., et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 2007, 107:563-571.
50. Logozzi M., De Milito A., Lugini L., Borghi M., Calabro L., Spada M., et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009, 4:e5219.
51. Zwicker J.I., Liebman H.A., Neuberg D., Lacroix R., Bauer K.A., Furie B.C., et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin. Cancer Res. 2009, 15:6830-6840.
52. Choi D.S., Park J.O., Jang S.C., Yoon Y.J., Jung J.W., Choi D.Y., et al. Proteomic analysis of microvesicles derived from human colorectal cancer ascites. Proteomics 2011, 11:2745-2751.
53. Rupp A.K., Rupp C., Keller S., Brase J.C., Ehehalt R., Fogel M., et al. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol. Oncol. 2011, 122:437-446.
54. Ohno S., Ishikawa A., Kuroda M. Ultrastructure of exosome. Jikkennigaku 2011, 29:420-422. (Japanese).